Metraipolis › archive › dc_58558bf2a348
Cost-utility analysis of three PD-1 inhibitors combined with chemotherapy in the first-line treatment of locally advanced or metastatic esophageal squamous… — Europe PMC PMID:42105156
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42105156
- DOI
- 10.1186/s13561-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T13:49:46.614Z
- SHA-256 of the archived text
c3ad24c03b9f242eb6cc18faa879ba57df69a47515ce2bd698159db59af4364a- Stable URL of this page
https://metraipolis.com/documento/dc_58558bf2a348
How to cite
Cost-utility analysis of three PD-1 inhibitors combined with chemotherapy in the first-line treatment of locally advanced or metastatic esophageal squamous… — Europe PMC PMID:42105156 — Europe PMC (en), https://europepmc.org/article/MED/42105156 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_58558bf2a348 (Metraipolis archive dc_58558bf2a348, sha256 c3ad24c03b9f242eb6cc18faa879ba57df69a47515ce2bd698159db59af4364a)
BibTeX
@misc{dc58558bf2a348,
title = {Cost-utility analysis of three PD-1 inhibitors combined with chemotherapy in the first-line treatment of locally advanced or metastatic esophageal squamous… — Europe PMC PMID:42105156},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42105156},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_58558bf2a348; sha256 c3ad24c03b9f242eb6cc18faa879ba57df69a47515ce2bd698159db59af4364a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42105156. Agents can read the archived copy with the MCP tool read_document.